CVS Group plc, a leading provider of integrated veterinary services in the UK and Australia, has confirmed the exercise of options by certain employees under the CVS Group 2020 SAYE Plan. This exercise resulted in the issuance of 5,468 new Ordinary Shares of 0.2 pence each. These shares were issued to satisfy the balance of Ordinary Shares arising from the SAYE Exercise and rank pari passu with the Company's existing Ordinary Shares.
Following the issuance, CVS Group plc now has a total issued share capital of 71,737,601 Ordinary Shares, each carrying one voting right, with none held in treasury. This figure will be used by shareholders as the denominator for the calculations to determine if they are required to notify their interest or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
CVS Group plc operates approximately 460 veterinary practices, including specialist referral hospitals and dedicated out-of-hours sites, alongside Laboratories, Crematoria, and an online retail business. The company is focused on providing high-quality clinical services to its clients and their animals, with dedicated clinical teams and support colleagues at the core of its strategy.
For further information, shareholders can contact CVS Group plc or its advisors, Peel Hunt LLP and Berenberg. The company's financial PR is handled by Camarco.
This news provides insight into the recent developments at CVS Group plc, shedding light on the exercise of options and the resulting impact on the company's total voting rights.